Metagenomics Sequencing Market worth USD 2564.01 million by 2027
The Market Statsville Group (MSG) publishes the new report on the "Metagenomics Sequencing Market by Product & Services (Reagents & Consumables, Instruments, and Services (Analysis & Data Interpretation Solutions and Metagenomic Sequencing Services)), by Technology (16S rRNA Sequencing, Whole Genome Sequencing & De Novo Assembly, Shotgun Metagenomics Sequencing, and Metatranscriptomics), by Application (Ecological & Environmental Metagenomics, Clinical Diagnostics, Drug Discovery, Biofuel, and Industrial Applications), by Region – Global Share and Forecast to 2027". The global metagenomics sequencing market size is expected to grow from USD 974.3 million in 2020 to USD 2564.01 million by 2027, at a CAGR of 17.5% during the forecast period. Metagenomics plays a vital role in the genomic field; besides applying metagenomics in biocatalysts from nature, it also has found applications in fields as diverse as bioremediation, ecological & environmental metagenomics, clinical diagnostic, drug discovery, and industrial application. Clinical diagnostic metagenomics enables pathogen detection by unbiased next-generation sequencing. Recently, metagenomic sequencing and bioinformatics technology have increased the adoption of precision diagnostic tests based on metagenomics sequencing. In addition, the DNA extracted from the desired organism then purified, cloned, and expressed in a heterologous host such as function-based screenings can be useful for discovering novel proteins such as antibiotics. Hence, such various applications supplement the market growth.
Get Full PDF Sample Copy of Report: https://www.marketstatsville.com/press-release/metagenomics-sequencing-market
Global Metagenomics Sequencing Market Segmentation
The overall metagenomics sequencing market has been segmented into product & services, technology, application, and region.
By Product & Services Outlook (Sales, USD Million, 2017-2027)
- Reagents & Consumables
- Analysis & Data Interpretation Solutions
- Metagenomic Sequencing Services
By Technology Outlook (Sales, USD Million, 2017-2027)
- Shotgun Metagenomics Sequencing
- 16S rRNA Sequencing
- Whole Genome Sequencing & De Novo Assembly
By Application Outlook (Sales, USD Million, 2017-2027)
- Drug Discovery
- Ecological & Environmental Metagenomics
- Clinical Diagnostics
- Industrial Applications
By Region Outlook (Sales, USD Million, 2017-2027)
- North America (US, Canada, Mexico)
- South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
- Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
- Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
- The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)
Make an Enquire before Purchase @: https://www.marketstatsville.com/buy-now/metagenomics-sequencing-market?opt=2950
Shotgun metagenomic sequencing, by technology, is estimated to hold the largest market share during the forecast period
By technology, the global metagenomic sequencing market is categorized into shotgun metagenomics sequencing, 16S rRNA sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. In 2020, shotgun metagenomic sequencing accounted for the largest market, with a 30.2% market share. The shotgun metagenomic sequencing segment is expected to showcase lucrative market growth during the forecast period. Factors such as advantages offered by shotgun sequencing are better than other technologies, growth in the adoption and preference toward shotgun metagenomic sequencing among researchers & healthcare professionals, and the surge in the number of metagenomic sequencing-based research activities are anticipated to propel the growth of the industry.
The rise in preference toward adopting shotguns due to better advantages is anticipated to help the global metagenomics sequencing market gain traction. Since the past few years, shotgun metagenomic sequencing has increased due to the application where all the genomes in DNA can be read with the help of shotgun metagenomic sequencing. There has been an increase in the number of product launches accomplished by players with shotgun metagenomic sequencing, which is expected to help the market generate higher revenue from this segment.
North America accounts for the largest market share in the metagenomic sequencing market 2020
The global metagenomics sequencing market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2020, North America accounted for the highest market share of 42.3% in the global metagenomics sequencing market and was anticipated to maintain its dominance throughout the forecast period. Stronghold on Deoxyribonucleic Acid (DNA) sequencing technologies due to the continuous improvement, availability, and accessibility of DNA sequencing in North America. Several global manufacturers of DNA sequencing, platforms, equipment, and technologies are highly active in North America, especially in the U.S. For instance, key market players, such as Illumina, Inc., Thermo Fisher Scientific Inc., and others, have their corporate presence in this region. Hence, most DNA sequencing products and platforms are first launched in the U.S. and then distributed to other world regions.
The key market players strive to introduce affordable DNA sequencing technologies in North America. This has provided momentum to the global metagenomics market in this region, enabling further investigation of microbial ecology. Moreover, the North American market has witnessed tremendous developments regarding the utilization of metagenomics products and technologies in biotechnology, which are expected to make way for new avenues and provide numerous growth opportunities for the expansion of the market.
This research report covers an analysis of the major firms' development and marketing tactics and a study of their product portfolios and winning methods in the plastic bottles and containers industry. Illumina, Inc., Macrogen Inc., BGI Genomics Co., Ltd., Eurofins Genomics, Oxford Nanopore Technologies Ltd, QIAGEN N.V., Swift Biosciences Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc. are among the prominent businesses represented. Each firm pursues its own business plan to gain a major market share.
Browse complete report: https://www.marketstatsville.com/metagenomics-sequencing-market